Publication
, Journal Article
Ishihama, N; Choi, S-W; Noutoshi, Y; Saska, I; Asai, S; Takizawa, K; He, SY; Osada, H; Shirasu, K
September 25, 2020
APA
Chicago
ICMJE
MLA
NLM
Ishihama, N., Choi, S.-W., Noutoshi, Y., Saska, I., Asai, S., Takizawa, K., … Shirasu, K. (2020). Oxicam-type nonsteroidal anti-inflammatory drugs inhibit NPR1-mediated salicylic acid pathway. https://doi.org/10.1101/2020.09.25.311100
Ishihama, Nobuaki, Seung-won Choi, Yoshiteru Noutoshi, Ivana Saska, Shuta Asai, Kaori Takizawa, Sheng Yang He, Hiroyuki Osada, and Ken Shirasu. “Oxicam-type nonsteroidal anti-inflammatory drugs inhibit NPR1-mediated salicylic acid pathway,” September 25, 2020. https://doi.org/10.1101/2020.09.25.311100.
Ishihama N, Choi S-W, Noutoshi Y, Saska I, Asai S, Takizawa K, et al. Oxicam-type nonsteroidal anti-inflammatory drugs inhibit NPR1-mediated salicylic acid pathway. 2020 Sep 25;
Ishihama, Nobuaki, et al. Oxicam-type nonsteroidal anti-inflammatory drugs inhibit NPR1-mediated salicylic acid pathway. Sept. 2020. Crossref, doi:10.1101/2020.09.25.311100.
Ishihama N, Choi S-W, Noutoshi Y, Saska I, Asai S, Takizawa K, He SY, Osada H, Shirasu K. Oxicam-type nonsteroidal anti-inflammatory drugs inhibit NPR1-mediated salicylic acid pathway. 2020 Sep 25;